Evaluation of Vascular Event Risk while on Long-term Anti-retroviral Suppressive Therapy [EVERLAST]: Protocol for a prospective observational study

BACKGROUND & OBJECTIVE: Cardiovascular disease (CVD) risk among the HIV population is high due to a combination of accelerated atherosclerosis from the pro-inflammatory milieu created by chronic HIV infection and the potentially adverse metabolic side effects from cART (combination antiretrovira...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarfo, Fred Stephen, Nichols, Michelle, Gebregziabher, Mulugeta, Tagge, Raelle, Asibey, Shadrack Osei, Jenkins, Carolyn, Ovbiagele, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460293/
https://www.ncbi.nlm.nih.gov/pubmed/31011634
http://dx.doi.org/10.1016/j.ensci.2019.100189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460293/
https://www.ncbi.nlm.nih.gov/pubmed/31011634
http://dx.doi.org/10.1016/j.ensci.2019.100189

Ejemplares similares